Enhanced skin permeation of piroxicam and pranoprofen induced from nanoparticles dispersed in propylene glycol aqueous solution

Journal of Drug Delivery Science and Technology

Volumn 22, Issue 2, 2012, Pages 131-137

  Ikeda, Y ^a,b   Higashi, K ^a   Moribe, K ^a   Yamamoto, K ^a  

^a CHIBA UNIVERSITY   (Japan)

^b SSP CO LTD   (Japan)

Author keywords

Cogrinding; Nanoparticle; Piroxicam; Pranoprofen; Skin permeation

Indexed keywords

DODECYL SULFATE SODIUM; HYDROXYPROPYLMETHYLCELLULOSE; NANOPARTICLE; PIROXICAM; PRANOPROFEN; PROPYLENE GLYCOL;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG SOLUBILITY; IN VITRO STUDY; MALE; MEMBRANE TRANSPORT; MOUSE; NONHUMAN; PARTICLE SIZE; SKIN DEFECT; SUSPENSION;

EID: 84859632845     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(12)50017-1     Document Type: Article

References (39)

1. Merisko-Liversidge E., Liversidge G.G., Cooper E.R. - Nanosizing: a formulation approach for poorly-water-soluble compounds. - Eur. J. Pharm. Sci., 18, 113-120, 2003. (Pubitemid 36184748)
2. Zili Z., Star S., Fessi H. - Preparation and characterization of poly-ε-caprolactone nanoparticles containing griseofulvin. - Int. J. Pharm., 294, 261-267, 2005. (Pubitemid 40462340)
3. Jinno J., Kamada N., Miyake M., Yamada K., Mukai T., Odomi M., Toguchi H., Liversidge G.G., Higaki K., Kimura T. - Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. - J. Control. Release, 111, 56-64, 2006. (Pubitemid 43289995)
4. Matteucci M.E., Brettmann B.K., Rogers T.L., Elder E.J., Williams III R.O., Johnston K.P. - Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media. - Mol. Pharm., 4, 782-793, 2007. (Pubitemid 350004278)
5. Mihranyan A., Stramme M. - Solubility of fractal nanoparticles. - Surf. Sci., 601, 315-319, 2007.
6. Wu J.Z., Ho P.C. - Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding. - Eur. J. Pharm. Sci., 29, 35-44, 2006.
7. Pongpeerapat A;., Wanawongthai C., Tozuka Y., Moribe K., Yamamoto K. - Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture. - Int. J. Pharm., 352, 309-316, 2008.
8. Shudo J., Pongpeerapat A., Wanawongthai C., Moribe K., Yamamoto K. - In vivo assessment of oral administration of probucol nanoparticles in rats. - Biol. Pharm. Bull., 31, 321-325, 2008. (Pubitemid 351198412)
9. Fukami T., Ishii T., Io T., Suzuki N., Suzuki T., Yamamoto K., Xu J., Ramamoorthy A., Tomono K. - Nanoparticle processing in the solid state dramatically increases the cell membrane permeation of a cholesterol-lowering drug, probucol. - Mol. Pharm., 6, 1029-1035, 2009.
10. Bisht S., Feldmann G., Koorstra J.M., Mullendore M., Alvarez H., Karikari C., Rudek M.A., Lee C.K., Maitra A., Maitra A. - In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities. - Mol. Cancer Ther., 7, 3878-3888, 2008.
11. Shaikh J., Ankola D.D., Beniwal V., Singh D., Ravi Kumar M.N.V. - Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. - Eur. J. Pharm. Sci., 37, 223-230, 2009.
12. Grenha A., Remuñan-López C., Carvalho E.L.S., Seijo B. - Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins. - Eur. J. Pharm. Biopharm., 69, 83-93, 2008.
13. Rajapaksa T.E., Stover-Hamer M., Fernandez X., Eckelhoefer H.A., Lo D.D. - Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery. - J. Control. Release, 142, 196-205, 2010.
14. Merisko-Liversidge E., McGurk S.L., Liversidge G.G. - Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulin. - Pharm. Res., 21, 1545-1553, 2004. (Pubitemid 41184382)
15. Patil Y., Sadhukha T., Ma L., Panyam J. - Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. - J. Control. Release, 136, 21-29, 2009.
16. Singka G.S.L., Samah N.A., Zulfakar M.H., Yurdasiper A., Heard C.M. - Enhanced topical delivery and anti-inflammatory activity of methotrexate from an activated nanogel. - Eur. J. Pharm. Biopharm., 76, 275-281, 2010.
17. Zhao Y., Brown M.B., Jones S.A. - The effects of particle properties on nanoparticle drug retention and release in dynamic minoxidil foams. - Int. J. Pharm., 383, 277-284, 2010.
18. Cheong H., Choi H. - Enhanced percutaneous absorption of piroxicam via salt formation with ethanolamines. - Pharm. Res., 19, 1375-1380, 2002.
19. Zhao L., Li Y., Fang L., Ren C., Xu Y., He Z. - Effect of O-acylmenthol and salt formation on the skin permeation of diclofenac acid. - Drug Dev. Ind. Pharm., 35, 814-826, 2009.
20. Cilurzo F, Minghetti R, Alberti E., Gennari C.G.M., Pallavicini M., Valoti E., Montanari L. - An investigation into the influence of counterion on the RS-propranolol and S-propranolol skin permeability. - J. Pharm. Sci., 99, 1217-1224, 2010.
21. Murthy S.N., Zhao Y., Sen A., Hui S.W. - Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation. - J. Control. Release, 99, 393-402, 2004. (Pubitemid 39296908)
22. Ventura C.A., Tommasini S., Falcone A., Giannone I., Paolino D., Sdrafkakis V., Mondello M.R., Puglisi G. - Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin. - Int. J. Pharm., 314, 37-45, 2006.
23. Mora M.J., Longhi M.R., Granero G.E. - Synthesis and characterization of binary and ternary complexes of diclofenac with a methyl-β-CD and monoethanolamine and in vitro transdermal evaluation. - Eur. J. Med. Chem., 45, 4079-4088, 2010.
24. Williams A.C., Barry B.W. - Penetration enhancers. - Adv. Drug Deliv. Rev., 56, 603-618, 2004.
25. Kimura C., Nakanishi T., Tojo K. - Skin permeation of ketotifen applied from stick-type formulation. - Eur. J. Pharm. Biopharm., 67, 420-424, 2007. (Pubitemid 47211906)
26. Cho C ., Choi J., Yang K., Shin S. - Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen ethylene vinyl acetate matrix containing penetration enhancer in rats. - Arch. Pharm. Res., 32, 747-753, 2009.
27. Alvarez-Román R., Naik A., Kalia Y.N., Guy R.H., Fessi H. - Skin penetration and distribution of polymeric nanoparticles. - J. Control. Release, 99, 53-62, 2004. (Pubitemid 39165733)
28. Vogt A., Combadiere B., Hadam S., Stieler K.M., Lademann J., Schaefer H., Autran B., Sterry W., Blume-Peytavi U. - 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. - J. Invest. Dermatol., 126, 1316-1322, 2006. (Pubitemid 43997914)
29. Tsujimoto H., Hara K., Tsukada Y., Huang C.C., Kawashima Y., Arakaki M., Okayasu H., Mimura H., Miwa N. - Evaluation of the permeability of hair growing ingredient encapsulated PLGA nanospheres to hair follicles and their hair growing effects. - Bioorg. Med. Chem. Lett., 17, 4771-4777, 2007. (Pubitemid 47187703)
30. Moribe K., Shibata M., Furuishi T., Higashi K., Tomono K., Yamamoto K. - Effect of particle size on skin permeation and retention of piroxicam in aqueous suspension. - Chem. Pharm. Bull., 58, 1096-1099, 2010.
31. Moser K., Kriwet K., Froehlich C., Kalia N.Y, Guy R.H. - Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug. - Pharm. Res., 18, 1006-1011, 2001. (Pubitemid 32799947)
32. Wanawongthai C., Pongpeerapat A., Higashi K., Tozuka Y., Moribe K., Yamamoto K. - Nanoparticle formation from probucol/PVP/sodium alkyl sulfate co-ground mixture. - Int. J. Pharm., 376, 169-175, 2009.
33. Griffiths H.A., Wilhelm K.P., Robinson M.K., Wang X.M., Mcfadden J., York M., Basketter D.A. - Interlaboratory evaluation of a human patch test for the identification of skin irritation potential/hazard. - Food Chem. Toxicol., 35, 255-260, 1997. (Pubitemid 27187459)
34. Nilsson S. - Interactions between water-soluble cellulose derivatives and surfactants. 1. The HPMC/SDS/water system. - Macramolecutes, 28, 7837-7844, 1995.
35. Irwin W.J., Sanderson F.D., Li Wan Po A. - Percutaneous absorption of ibuprofen: vehicle effects on transport through rat skin. - Int. J. Pharm., 66, 193-200, 1990.
36. Pellett M.A., Castellano S., Hadgraft J., Davis A.F. - The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. - J. Control. Release, 46, 205-214, 1997. (Pubitemid 27132844)
37. Ross J.S., Shah J.C. - Reduction in skin permeation of N,N-diethyl-m-toluamide (DEET) by altering the skin/vehicle partition coefficient. - J. Control. Release, 67, 211-221, 2000. (Pubitemid 30303836)
38. Pellett M.A., Davis A.F., Hadgraft J. - Effect of supersaturation on membrane transport: 2. Piroxicam. - Int. J. Pharm., 111, 1-6, 1994. (Pubitemid 24277372)
39. Walters K.A. - Dermatological and transdermal formulations. - In: Watkinson A.C., Brain K.R. (Eds.), Basic Mathematical Principles in Skin Permeation, Marcel Dekker Inc., New York, 2002, pp. 65-73.